{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Insulin resistance", "Medicinal plants", "Metabolic syndrome", "Type 2 diabetes"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33861444", "DateCompleted": {"Year": "2021", "Month": "04", "Day": "20"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "10"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1007/978-3-030-64872-5_13"], "Journal": {"ISSN": "0065-2598", "JournalIssue": {"Volume": "1308", "PubDate": {"Year": "2021"}}, "Title": "Advances in experimental medicine and biology", "ISOAbbreviation": "Adv Exp Med Biol"}, "ArticleTitle": "Medicinal Plants and Phytochemicals Regulating Insulin Resistance and Glucose Homeostasis in Type 2 Diabetic Patients: A Clinical Review.", "Pagination": {"StartPage": "161", "EndPage": "183", "MedlinePgn": "161-183"}, "Abstract": {"AbstractText": ["Diabetes is a major health problem affecting more than four hundred million adults worldwide. The transition from normal glucose tolerance to type 2 diabetes (T2D) is preceded by increased Insulin resistance (IR), an independent predictor of the development of T2D in high risk (e.g. obese populations, pre-diabetes) individuals. Insulin deficiency resulting from increased IR results in progressive glucose homeostasis dysfunction. Data has shown that IR is affected by many different factors such as genetics, age, exercise, dietary nutrients, obesity, and body fat distribution. One of the most important factors is diet, which plays an essential role in addressing T2D and metabolic syndrome. Nutraceuticals and medicinal plants have been shown to have efficacy in preventing chronic diseases like cancer, non-alcoholic fatty liver disease (NAFLD), cardiovascular disease, diabetes mellitus and metabolic syndrome, likely through the anti-inflammatory properties found in nutraceuticals. However, the effect of these compounds, including traditional plant medicines, herbal formulations or their extracts on IR have not been systematically investigated. The objective of this review was to assess the reported effects of medicinal plants and bioactive natural compounds on IR. The findings confirm that most of the herbal bioactive compounds including resveratrol, garlic, curcumin, cinnamon, ginger, nuts, berberine, anthocyanin, soybean, flaxseed, vegetable oils, and soluble fibers have benefit in their efficacy for decreasing IR, fasting blood sugar (FBS), fasting insulin and HbA1c."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Community Nutrition, School of Nutrition and Food Science, Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran."}], "LastName": "Mahdavi", "ForeName": "Atena", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Community Nutrition, School of Nutrition and Food Science, Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran."}], "LastName": "Bagherniya", "ForeName": "Mohammad", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Students' Research Committee, Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran."}], "LastName": "Mirenayat", "ForeName": "Mohammad Sadegh", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Weill Cornell Medicine Qatar, Doha, Qatar."}], "LastName": "Atkin", "ForeName": "Stephen L", "Initials": "SL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Applied Biomedical Research Center, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir."}, {"Identifier": [], "Affiliation": "Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir."}, {"Identifier": [], "Affiliation": "School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. sahebkara@mums.ac.ir."}, {"Identifier": [], "Affiliation": "Polish Mother's Memorial Hospital Research Institute (PMMHRI), Lodz, Poland. sahebkara@mums.ac.ir."}], "LastName": "Sahebkar", "ForeName": "Amirhossein", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Adv Exp Med Biol", "NlmUniqueID": "0121103", "ISSNLinking": "0065-2598"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Blood Glucose"}, {"RegistryNumber": "0", "NameOfSubstance": "Insulin"}, {"RegistryNumber": "0", "NameOfSubstance": "Phytochemicals"}, {"RegistryNumber": "IY9XDZ35W2", "NameOfSubstance": "Glucose"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Blood Glucose"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Diabetes Mellitus, Type 2"}, {"QualifierName": [], "DescriptorName": "Glucose"}, {"QualifierName": [], "DescriptorName": "Homeostasis"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Insulin"}, {"QualifierName": [], "DescriptorName": "Insulin Resistance"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Phytochemicals"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Diab M, Barhoosh HA, Daoudi B, AlMukdad SI, Zaghloul NH, Ashour M et al (2018) Prevention and screening recommendations in type 2 diabetes: review and critical appraisal of clinical practice guidelines. Prim Care Diabetes 13:197", "ArticleIdList": ["30553698"]}, {"Citation": "Zimmet PZ, Magliano DJ, Herman WH, Shaw JE (2014) Diabetes: a 21st century challenge. Lancet Diabetes Endocrinol 2(1):56\u201364", "ArticleIdList": ["24622669"]}, {"Citation": "Chatterjee S, Khunti K, Davies MJ (2017) Type 2 diabetes. Lancet 389(10085):2239\u20132251", "ArticleIdList": ["28190580"]}, {"Citation": "Chen L, Magliano DJ, Zimmet PZ (2012) The worldwide epidemiology of type 2 diabetes mellitus\u2014present and future perspectives. Nat Rev Endocrinol 8(4):228"}, {"Citation": "National Heart L, Institute B (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Obes Res 6:651S\u2013210S"}, {"Citation": "Hardy OT, Czech MP, Corvera S (2012) What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes 19(2):81", "ArticleIdList": ["22327367", "4038351"]}, {"Citation": "Martin BC, Warram JH, Krolewski A, Soeldner J, Kahn C, Bergman R (1992) Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340(8825):925\u2013929", "ArticleIdList": ["1357346"]}, {"Citation": "Barroso I, Gurnell M, Crowley V, Agostini M, Schwabe J, Soos M et al (1999) Dominant negative mutations in human PPAR\u03b3 associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 402(6764):880", "ArticleIdList": ["10622252"]}, {"Citation": "Gajovic N, Jovanovic I, Ilic A, Jeremic N, Jakovljevic V, Arsenijevic N et al (2016) Diabetes mellitus directs NKT cells toward type 2 and regulatory phenotype/diabetes Melitus Usmerava Diferencijaciju NKT Celija U Pravcu Tip 2 I Regulatornog Fenotipa. Serbian J Exp Clin Res 17(1):35\u201341"}, {"Citation": "Tab\u00e1k AG, Jokela M, Akbaraly TN, Brunner EJ, Kivim\u00e4ki M, Witte DR (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373(9682):2215\u20132221", "ArticleIdList": ["19515410", "2726723"]}, {"Citation": "Jia G, DeMarco VG, Sowers JR (2016) Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy. Nat Rev Endocrinol 12(3):144", "ArticleIdList": ["26678809"]}, {"Citation": "Isfort M, Stevens SC, Schaffer S, Jong CJ, Wold LE (2014) Metabolic dysfunction in diabetic cardiomyopathy. Heart Fail Rev 19(1):35\u201348", "ArticleIdList": ["23443849"]}, {"Citation": "Adeghate E, Singh J (2014) Structural changes in the myocardium during diabetes-induced cardiomyopathy. Heart Fail Rev 19(1):15\u201323", "ArticleIdList": ["23467937"]}, {"Citation": "Reaven GM (2008) Insulin resistance: the link between obesity and cardiovascular disease. Endocrinol Metab Clin N Am 37(3):581\u2013601"}, {"Citation": "Mart\u00edn-Gall\u00e1n P, Carrascosa A, Gussiny\u00e9 M, Dom\u00ednguez C (2003) Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications. Free Radic Biol Med 34(12):1563\u20131574", "ArticleIdList": ["12788476"]}, {"Citation": "Varva\u0159ovsk\u00e1 J, Racek J, Sto\u017eick\u00fd F, Sou\u010dek J, Trefil L, Pomaha\u010dov\u00e1 R (2003) Parameters of oxidative stress in children with type 1 diabetes mellitus and their relatives. J Diabetes Complicat 17(1):7\u201310"}, {"Citation": "Zhang P, Liu B, Seo MS, Rhee SG, Obeid LM (1997) Thioredoxin peroxidase is a novel inhibitor of apoptosis with a mechanism distinct from that of Bcl-2. J Biol Chem 272(49):30615\u201330618", "ArticleIdList": ["9388194"]}, {"Citation": "Nishikawa T, Edelstein D, Brownlee M (2000) The missing link: a single unifying mechanism for diabetic complications. Kidney Int 58:S26\u2013S30"}, {"Citation": "Maddux BA, See W, Lawrence JC, Goldfine AL, Goldfine ID, Evans JL (2001) Protection against oxidative stress\u2014induced insulin resistance in rat L6 muscle cells by micromolar concentrations of \u03b1-lipoic acid. Diabetes 50(2):404\u2013410", "ArticleIdList": ["11272154"]}, {"Citation": "Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444(7121):840", "ArticleIdList": ["17167471"]}, {"Citation": "Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM et al (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436(7049):356", "ArticleIdList": ["16034410"]}, {"Citation": "Chen M, Bergman R, Porte D Jr (1988) Insulin resistance and \u03b2-cell dysfunction in aging: the importance of dietary carbohydrate. J Clin Endocrinol Metab 67(5):951\u2013957", "ArticleIdList": ["3053750"]}, {"Citation": "Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A et al (2009) Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15(8):930", "ArticleIdList": ["19633656", "3115752"]}, {"Citation": "Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M et al (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15(8):914", "ArticleIdList": ["19633658"]}, {"Citation": "Kim MS, Lee MS, Kown DY (2011) Inflammation-mediated obesity and insulin resistance as targets for nutraceuticals. Ann N Y Acad Sci 1229(1):140\u2013146", "ArticleIdList": ["21793849"]}, {"Citation": "DeFronzo RA (1979) Glucose intolerance and aging: evidence for tissue insensitivity to insulin. Diabetes 28(12):1095\u20131101", "ArticleIdList": ["510806"]}, {"Citation": "Chen M, Bergman R, Pacini G, Porte D Jr (1985) Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased \u03b2-cell function. J Clin Endocrinol Metab 60(1):13\u201320", "ArticleIdList": ["3880560"]}, {"Citation": "Prigeon RL, Kahn SE, Porte D Jr (1995) Changes in insulin sensitivity, glucose effectiveness, and B-cell function in regularly exercising subjects. Metabolism 44(10):1259\u20131263", "ArticleIdList": ["7476281"]}, {"Citation": "Chen M, Halter JB, Porte D Jr (1987) The role of dietary carbohydrate in the decreased glucose tolerance of the elderly. J Am Geriatr Soc 35(5):417\u2013424", "ArticleIdList": ["3033045"]}, {"Citation": "Olefsky J, Farquhar JW, Reaven G (1973) Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects. Diabetes 22(7):507\u2013513", "ArticleIdList": ["4719190"]}, {"Citation": "BEARD JC, WARD WK, WALLUM BJ, PORTE JRD (1987) Relationship of islet function to insulin action in human obesity. J Clin Endocrinol Metab 65(1):59\u201364", "ArticleIdList": ["3294880"]}, {"Citation": "Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL (1999) Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 48(4):839\u2013847", "ArticleIdList": ["10102702"]}, {"Citation": "Cnop M, Landchild MJ, Vidal J, Havel PJ, Knowles NG, Carr DR et al (2002) The concurrent accumulation of intra-abdominal and subcutaneous fat explains the association between insulin resistance and plasma leptin concentrations: distinct metabolic effects of two fat compartments. Diabetes 51(4):1005\u20131015", "ArticleIdList": ["11916919"]}, {"Citation": "Schwartz RS, Shuman WP, Larson V, Cain KC, Fellingham GW, Beard JC et al (1991) The effect of intensive endurance exercise training on body fat distribution in young and older men. Metabolism 40(5):545\u2013551", "ArticleIdList": ["2023542"]}, {"Citation": "Zheng Y, Ley SH, Hu FB (2018) Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol 14(2):88", "ArticleIdList": ["29219149"]}, {"Citation": "McCarty MF (2005) Nutraceutical resources for diabetes prevention\u2013an update. Med Hypotheses 64(1):151\u2013158", "ArticleIdList": ["15533633"]}, {"Citation": "Saxena M, Saxena J, Nema R, Singh D, Gupta A (2013) Phytochemistry of medicinal plants. J Pharmacogn Phytochem 1(6):168"}, {"Citation": "Babu PA, Suneetha G, Boddepalli R, Lakshmi VV, Rani TS, RamBabu Y et al (2006) A database of 389 medicinal plants for diabetes. Bioinformation 1(4):130", "ArticleIdList": ["17597872", "1891668"]}, {"Citation": "Dav\u00ec G, Santilli F, Patrono C (2010) Nutraceuticals in diabetes and metabolic syndrome. Cardiovasc Ther 28(4):216\u2013226", "ArticleIdList": ["20633024"]}, {"Citation": "Van Winkel R, De Hert M, Van Eyck D, Hanssens L, Wampers M, Scheen A et al (2008) Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder. Bipolar Disord 10(2):342\u2013348", "ArticleIdList": ["18271914"]}, {"Citation": "Derosa G, Limas CP, Mac\u00edas PC, Estrella A, Maffioli P (2014) Dietary and nutraceutical approach to type 2 diabetes. Arch Med Sci: AMS 10(2):336", "ArticleIdList": ["24904670"]}, {"Citation": "Banach M, Patti AM, Giglio RV, Cicero AFG, Atanasov AG, Bajraktari G, et al (2018) The role of nutraceuticals in statin intolerant patients. J Am Coll Cardiol 72(1):96\u2013118. https://doi.org/10.1016/j.jacc.2018.04.040"}, {"Citation": "Pendurthi UR, Rao LVM (2000) Suppression of transcription factor Egr-1 by curcumin. Thromb Res 97(4):179\u2013189", "ArticleIdList": ["10674404"]}, {"Citation": "Zare Javid A, Hormoznejad R, Yousefimanesh HA, Zakerkish M, Haghighi-zadeh MH, Dehghan P et al (2017) The impact of resveratrol supplementation on blood glucose, insulin, insulin resistance, triglyceride, and periodontal markers in type 2 diabetic patients with chronic periodontitis. Phytother Res 31(1):108\u2013114", "ArticleIdList": ["27807887"]}, {"Citation": "Brasny\u00f3 P, Moln\u00e1r GA, Moh\u00e1s M, Mark\u00f3 L, Laczy B, Cseh J et al (2011) Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr 106(3):383\u2013389", "ArticleIdList": ["21385509"]}, {"Citation": "Movahed A, Nabipour I, Lieben Louis X, Thandapilly SJ, Yu L, Kalantarhormozi M et al (2013) Antihyperglycemic effects of short term resveratrol supplementation in type 2 diabetic patients. Evid Based Complement Alternat Med 2013:1"}, {"Citation": "Bhatt JK, Thomas S, Nanjan MJ (2012) Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res 32(7):537\u2013541", "ArticleIdList": ["22901562"]}, {"Citation": "Bo S, Ponzo V, Ciccone G, Evangelista A, Saba F, Goitre I et al (2016) Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial. Pharmacol Res 111:896\u2013905", "ArticleIdList": ["27520400"]}, {"Citation": "Talaei B, Amouzegar A, Sahranavard S, Hedayati M, Mirmiran P, Azizi F (2017) Effects of cinnamon consumption on glycemic indicators, advanced glycation end products, and antioxidant status in type 2 diabetic patients. Nutrients 9(9):991", "ArticleIdList": ["5622751"]}, {"Citation": "Solomon TP, Blannin AK (2009) Changes in glucose tolerance and insulin sensitivity following 2 weeks of daily cinnamon ingestion in healthy humans. Eur J Appl Physiol 105(6):969", "ArticleIdList": ["19159947"]}, {"Citation": "Akilen R, Tsiami A, Devendra D, Robinson N (2010) Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. Diabet Med 27(10):1159\u20131167", "ArticleIdList": ["20854384"]}, {"Citation": "Vanschoonbeek K, Thomassen BJ, Senden JM, Wodzig WK, van Loon LJ (2006) Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. J Nutr 136(4):977\u2013980", "ArticleIdList": ["16549460"]}, {"Citation": "Mozaffari-Khosravi H, Talaei B, Jalali B-A, Najarzadeh A, Mozayan MR (2014) The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Complement Ther Med 22(1):9\u201316", "ArticleIdList": ["24559810"]}, {"Citation": "Shidfar F, Rajab A, Rahideh T, Khandouzi N, Hosseini S, Shidfar S (2015) The effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetes. J Complement Integr Med 12(2):165\u2013170", "ArticleIdList": ["25719344"]}, {"Citation": "Mahluji S, Attari VE, Mobasseri M, Payahoo L, Ostadrahimi A, Golzari SE (2013) Effects of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients. Int J Food Sci Nutr 64(6):682\u2013686", "ArticleIdList": ["23496212"]}, {"Citation": "Arablou T, Aryaeian N, Valizadeh M, Sharifi F, Hosseini A, Djalali M (2014) The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus. Int J Food Sci Nutr 65(4):515\u2013520", "ArticleIdList": ["24490949"]}, {"Citation": "Yin J, Xing H, Ye J (2008) Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 57(5):712\u2013717", "ArticleIdList": ["18442638", "2410097"]}, {"Citation": "Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N et al (2008) Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab 93(7):2559\u20132565", "ArticleIdList": ["18397984"]}, {"Citation": "Shidfar F, Ebrahimi SS, Hosseini S, Heydari I, Shidfar S, Hajhassani G (2012) The effects of Berberis vulgaris fruit extract on serum lipoproteins, apoB, apoA-I, homocysteine, glycemic control and total antioxidant capacity in type 2 diabetic patients. Iran J Pharm Res: IJPR 11(2):643", "ArticleIdList": ["24250489"]}, {"Citation": "Atkin M, Laight D, Cummings MH (2016) The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trial. J Diabetes Complicat 30(4):723\u2013727"}, {"Citation": "Ghorbani A, Zarvandi M, Rakhshandeh H (2019) A randomized controlled trial of a herbal compound for improving metabolic parameters in diabetic patients with uncontrolled dyslipidemia. Endocr Metab Immune Disord Drug Targets (Formerly Curr Drug Targets Immune Endocr Metab Disord) 19(7):1075\u20131082"}, {"Citation": "Li D, Zhang Y, Liu Y, Sun R, Xia M (2015) Purified anthocyanin supplementation reduces dyslipidemia, enhances antioxidant capacity, and prevents insulin resistance in diabetic patients. J Nutr 145(4):742\u2013748", "ArticleIdList": ["25833778"]}, {"Citation": "Moazen S, Amani R, Rad AH, Shahbazian H, Ahmadi K, Jalali MT (2013) Effects of freeze-dried strawberry supplementation on metabolic biomarkers of atherosclerosis in subjects with type 2 diabetes: a randomized double-blind controlled trial. Ann Nutr Metab 63(3):256\u2013264", "ArticleIdList": ["24334868"]}, {"Citation": "Banihani S, Makahleh S, El-Akawi Z, Al-Fashtaki R, Khabour O, Gharibeh M et al (2014) Fresh pomegranate juice ameliorates insulin resistance, enhances \u03b2-cell function, and decreases fasting serum glucose in type 2 diabetic patients. Nutr Res 34(10):862\u2013867", "ArticleIdList": ["25223711"]}, {"Citation": "Liu C-Y, Huang C-J, Huang L-H, Chen I-J, Chiu J-P, Hsu C-H (2014) Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial. PLoS One 9(3):e91163", "ArticleIdList": ["24614112", "3948786"]}, {"Citation": "Hua C, Liao Y, Lin S, Tsai T, Huang C, Chou P (2011) Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebocontrolled clinical trial. Altern Med Rev 16(2):157\u2013163"}, {"Citation": "Fukino Y, Shimbo M, Aoki N, OKUBO T, ISO H (2005) Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sci Vitaminol 51(5):335\u2013342", "ArticleIdList": ["16392704"]}, {"Citation": "Ryu O, Lee J, Lee K, Kim H, Seo JA, Kim SG et al (2006) Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract 71(3):356\u2013358", "ArticleIdList": ["16169629"]}, {"Citation": "MacKenzie T, Leary L, Brooks WB (2007) The effect of an extract of green and black tea on glucose control in adults with type 2 diabetes mellitus: double-blind randomized study. Metabolism 56(10):1340\u20131344", "ArticleIdList": ["17884442"]}, {"Citation": "Ahn HY, Kim M, Seo CR, Yoo HJ, Lee S-H, Lee JH (2018) The effects of Jerusalem artichoke and fermented soybean powder mixture supplementation on blood glucose and oxidative stress in subjects with prediabetes or newly diagnosed type 2 diabetes. Nutr Diabetes 8(1):1\u201313"}, {"Citation": "Kim J-I, Kim J, Kang M-J, Lee M-S, Kim J-J, Cha I-J (2005) Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study. Eur J Clin Nutr 59(3):456", "ArticleIdList": ["15536472"]}, {"Citation": "Sathyapalan T, Aye M, Rigby A, Fraser W, Kilpatrick E, Atkin S (2017) Effect of soy on bone turn-over markers in men with type 2 diabetes and hypogonadism\u2013a randomised controlled study. Sci Rep 7(1):1\u20135"}, {"Citation": "Konya J, Sathyapalan T, Kilpatrick ES, Atkin SL (2019) The effects of soy protein and cocoa with or without isoflavones on glycemic control in type 2 diabetes. A double-blind, randomized, placebo-controlled study. Front Endocrinol 10:296"}, {"Citation": "Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA et al (2002) Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care 25(10):1709\u20131714", "ArticleIdList": ["12351466"]}, {"Citation": "Gonz\u00e1lez S, Jayagopal V, Kilpatrick ES, Chapman T, Atkin SL (2007) Effects of isoflavone dietary supplementation on cardiovascular risk factors in type 2 diabetes. Diabetes Care 30(7):1871\u20131873", "ArticleIdList": ["17468359"]}, {"Citation": "Soleimani Z, Hashemdokht F, Bahmani F, Taghizadeh M, Memarzadeh MR, Asemi Z (2017) Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: a randomized, double-blind, placebo-controlled trial. J Diabetes Complicat 31(9):1394\u20131400"}, {"Citation": "Zheng JS, Lin M, Fang L, Yu Y, Yuan L, Jin Y et al (2016) Effects of n-3 fatty acid supplements on glycemic traits in Chinese type 2 diabetic patients: a double-blind randomized controlled trial. Mol Nutr Food Res 60(10):2176\u20132184", "ArticleIdList": ["27279274"]}, {"Citation": "Soleimani A, Taghizadeh M, Bahmani F, Badroj N, Asemi Z (2017) Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial. Clin Nutr 36(1):79\u201384", "ArticleIdList": ["26611718"]}, {"Citation": "Foster M, Chu A, Petocz P, Samman S (2014) Zinc transporter gene expression and glycemic control in post-menopausal women with type 2 diabetes mellitus. J Trace Elem Med Biol 28(4):448\u2013452", "ArticleIdList": ["25156968"]}, {"Citation": "Panahi Y, Khalili N, Sahebi E, Namazi S, Simental-Mend\u00eda LE, Majeed M et al (2018) Effects of curcuminoids plus piperine on glycemic, hepatic and inflammatory biomarkers in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled trial. Drug Res 68(07):403\u2013409"}, {"Citation": "Na LX, Li Y, Pan HZ, Zhou XL, Sun DJ, Meng M et al (2013) Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Mol Nutr Food Res 57(9):1569\u20131577", "ArticleIdList": ["22930403"]}, {"Citation": "Hodaei H, Adibian M, Nikpayam O, Hedayati M, Sohrab G (2019) The effect of curcumin supplementation on anthropometric indices, insulin resistance and oxidative stress in patients with type 2 diabetes: a randomized, double-blind clinical trial. Diabetol Metab Syndr 11(1):41", "ArticleIdList": ["31149032", "6537430"]}, {"Citation": "Thota RN, Acharya SH, Garg ML (2019) Curcumin and/or omega-3 polyunsaturated fatty acids supplementation reduces insulin resistance and blood lipids in individuals with high risk of type 2 diabetes: a randomised controlled trial. Lipids Health Dis 18(1):31", "ArticleIdList": ["30684965", "6347796"]}, {"Citation": "Asadi S, Gholami MS, Siassi F, Qorbani M, Khamoshian K, Sotoudeh G (2019) Nano curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: a randomized double-blind placebo-controlled clinical trial. Complement Ther Med 43:253\u2013260", "ArticleIdList": ["30935539"]}, {"Citation": "Rabiei K, Ebrahimzadeh MA, Saeedi M, Bahar A, Akha O, Kashi Z (2018) Effects of a hydroalcoholic extract of Juglans regia (walnut) leaves on blood glucose and major cardiovascular risk factors in type 2 diabetic patients: a double-blind, placebo-controlled clinical trial. BMC Complement Altern Med 18(1):206", "ArticleIdList": ["29973195", "6031195"]}, {"Citation": "Hosseini S, Jamshidi L, Mehrzadi S, Mohammad K, Najmizadeh AR, Alimoradi H et al (2014) Effects of Juglans regia L. leaf extract on hyperglycemia and lipid profiles in type two diabetic patients: a randomized double-blind, placebo-controlled clinical trial. J Ethnopharmacol 152(3):451\u2013456", "ArticleIdList": ["24462785"]}, {"Citation": "Parham M, Heidari S, Khorramirad A, Hozoori M, Hosseinzadeh F, Bakhtyari L et al (2014) Effects of pistachio nut supplementation on blood glucose in patients with type 2 diabetes: a randomized crossover trial. Rev Diabet Stud: RDS 11(2):190", "ArticleIdList": ["25396407"]}, {"Citation": "Hern\u00e1ndez-Alonso P, Salas-Salvad\u00f3 J, Baldrich-Mora M, Juanola-Falgarona M, Bull\u00f3 M (2014) Beneficial effect of pistachio consumption on glucose metabolism, insulin resistance, inflammation, and related metabolic risk markers: a randomized clinical trial. Diabetes Care 37(11):3098\u20133105", "ArticleIdList": ["25125505"]}, {"Citation": "Li S-C, Liu Y-H, Liu J-F, Chang W-H, Chen C-M, Chen C-YO (2011) Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metabolism 60(4):474\u2013479", "ArticleIdList": ["20580779"]}, {"Citation": "Jenkins DJ, Kendall CW, Vuksan V, Faulkner D, Augustin LS, Mitchell S et al (2014) Effect of lowering the glycemic load with canola oil on glycemic control and cardiovascular risk factors: a randomized controlled trial. Diabetes Care 37(7):1806\u20131814", "ArticleIdList": ["24929428"]}, {"Citation": "Sarbolouki S, Javanbakht MH, Derakhshanian H, Hosseinzadeh P, Zareei M, Hashemi SB et al (2013) Eicosapentaenoic acid improves insulin sensitivity and blood sugar in overweight type 2 diabetes mellitus patients: a double-blind randomised clinical trial. Singap Med J 54(7):387\u2013390"}, {"Citation": "Mostad IL, Bjerve KS, Bjorgaas MR, Lydersen S, Grill V (2006) Effects of n\u2212 3 fatty acids in subjects with type 2 diabetes: reduction of insulin sensitivity and time-dependent alteration from carbohydrate to fat oxidation. Am J Clin Nutr 84(3):540\u2013550", "ArticleIdList": ["16960167"]}, {"Citation": "Jacobo-Cejudo MG, Vald\u00e9s-Ramos R, Guadarrama-L\u00f3pez AL, Pardo-Morales R-V, Mart\u00ednez-Carrillo BE, Harbige LS (2017) Effect of n-3 polyunsaturated fatty acid supplementation on metabolic and inflammatory biomarkers in type 2 diabetes mellitus patients. Nutrients 9(6):573", "ArticleIdList": ["5490552"]}, {"Citation": "Ogawa S, Abe T, Nako K, Okamura M, Senda M, Sakamoto T et al (2013) Eicosapentaenoic acid improves glycemic control in elderly bedridden patients with type 2 diabetes. Tohoku J Exp Med 231(1):63\u201374", "ArticleIdList": ["24067797"]}, {"Citation": "Kamalpour M, Ghalandari H, Nasrollahzadeh J (2018) Short-term supplementation of a moderate carbohydrate diet with psyllium reduces fasting plasma insulin and tumor necrosis factor-\u03b1 in patients with type 2 diabetes mellitus. J Diet Suppl 15(4):507\u2013515", "ArticleIdList": ["28956658"]}, {"Citation": "Dall\u2019Alba V, Silva FM, Antonio JP, Steemburgo T, Royer CP, Almeida JC et al (2013) Improvement of the metabolic syndrome profile by soluble fibre\u2013guar gum\u2013in patients with type 2 diabetes: a randomised clinical trial. Br J Nutr 110(9):1601\u20131610", "ArticleIdList": ["23551992"]}, {"Citation": "Abutair AS, Naser IA, Hamed AT (2016) Soluble fibers from psyllium improve glycemic response and body weight among diabetes type 2 patients (randomized control trial). Nutr J 15(1):86", "ArticleIdList": ["27733151", "5062871"]}, {"Citation": "Shakibaei M, Harikumar KB, Aggarwal BB (2009) Resveratrol addiction: to die or not to die. Mol Nutr Food Res 53(1):115\u2013128", "ArticleIdList": ["19072742"]}, {"Citation": "Shankar S, Singh G, Srivastava RK (2007) Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential. Front Biosci 12:4839\u20134854", "ArticleIdList": ["17569614"]}, {"Citation": "Saiko P, Szakmary A, Jaeger W, Szekeres T (2008) Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res 658(1\u20132):68\u201394", "ArticleIdList": ["17890139"]}, {"Citation": "Liu K, Zhou R, Wang B, Mi M-T (2014) Effect of resveratrol on glucose control and insulin sensitivity: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr 99(6):1510\u20131519", "ArticleIdList": ["24695890"]}, {"Citation": "Qin B, Polansky MM, Sato Y, Adeli K, Anderson RA (2009) Cinnamon extract inhibits the postprandial overproduction of apolipoprotein B48-containing lipoproteins in fructose-fed animals. J Nutr Biochem 20(11):901\u2013908", "ArticleIdList": ["18993048"]}, {"Citation": "Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ (2013) Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med 11(5):452\u2013459", "ArticleIdList": ["24019277", "3767714"]}, {"Citation": "Khan A, Safdar M, Ali Khan MM, Khattak KN, Anderson RA (2003) Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care 26(12):3215\u20133218", "ArticleIdList": ["14633804"]}, {"Citation": "Sheng X, Zhang Y, Gong Z, Huang C, Zang YQ (2008) Improved insulin resistance and lipid metabolism by cinnamon extract through activation of peroxisome proliferator-activated receptors. PPAR Res 2008:581348", "ArticleIdList": ["19096709", "2602825"]}, {"Citation": "Crawford P (2009) Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med 22(5):507\u2013512", "ArticleIdList": ["19734396"]}, {"Citation": "Qin B, Panickar KS, Anderson RA (2010) Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes. J Diabetes Sci Technol 4(3):685\u2013693", "ArticleIdList": ["20513336", "2901047"]}, {"Citation": "Shukla Y, Singh M (2007) Cancer preventive properties of ginger: a brief review. Food Chem Toxicol 45(5):683\u2013690", "ArticleIdList": ["17175086"]}, {"Citation": "Grzanna R, Lindmark L, Frondoza CG (2005) Ginger\u2014an herbal medicinal product with broad anti-inflammatory actions. J Med Food 8(2):125\u2013132", "ArticleIdList": ["16117603"]}, {"Citation": "Ali BH, Blunden G, Tanira MO, Nemmar A (2008) Some phytochemical, pharmacological and toxicological properties of ginger (Zingiber officinale roscoe): a review of recent research. Food Chem Toxicol 46(2):409\u2013420", "ArticleIdList": ["17950516"]}, {"Citation": "Pirillo A, Catapano AL (2015) Berberine, a plant alkaloid with lipid-and glucose-lowering properties: from in vitro evidence to clinical studies. Atherosclerosis 243(2):449\u2013461", "ArticleIdList": ["26520899"]}, {"Citation": "Liu Y, Zhang L, Song H, Ji G (2013) Update on berberine in nonalcoholic fatty liver disease. Evid Based Complement Alternat Med 2013:308134", "ArticleIdList": ["23843872", "3703418"]}, {"Citation": "Bagherniya M, Nobili V, Blesso CN, Sahebkar A (2018) Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: a clinical review. Pharmacol Res 130:213\u2013240", "ArticleIdList": ["29287685"]}, {"Citation": "Suleria HAR, Butt MS, Khalid N, Sultan S, Raza A, Aleem M et al (2015) Garlic (Allium sativum): diet based therapy of 21st century\u2013a review. Asian Pac J Trop Dis 5(4):271\u2013278"}, {"Citation": "Tsai C-W, Chen H-W, Sheen L-Y, Lii C-K (2012) Garlic: health benefits and actions. Biomedicine 2(1):17\u201329"}, {"Citation": "Borek C (2001) Antioxidant health effects of aged garlic extract. J Nutr 131(3):1010S\u20131015S", "ArticleIdList": ["11238807"]}, {"Citation": "Aamir K, Khan HU, Sethi G, Hossain MA, Arya A (2020) Wnt signaling mediates TLR pathway and promote unrestrained adipogenesis and metaflammation: therapeutic targets for obesity and type 2 diabetes. Pharmacol Res 152:104602", "ArticleIdList": ["31846761"]}, {"Citation": "Abdallah M, Altass HM, Al Jahdaly BA, Salem MM (2018) Some natural aqueous extracts of plants as green inhibitor for carbon steel corrosion in 0.5 M sulfuric acid. Green Chem Lett Rev 11(3):189\u2013196"}, {"Citation": "Abebe W (2019) Review of herbal medications with the potential to cause bleeding: dental implications, and risk prediction and prevention avenues. EPMA J 10(1):51\u201364", "ArticleIdList": ["30984314", "6459456"]}, {"Citation": "Wang Y, Zhao L, Wang D, Huo Y, Ji B (2016) Anthocyanin-rich extracts from blackberry, wild blueberry, strawberry, and chokeberry: antioxidant activity and inhibitory effect on oleic acid-induced hepatic steatosis in vitro. J Sci Food Agric 96(7):2494\u20132503", "ArticleIdList": ["26250597"]}, {"Citation": "Valenti L, Riso P, Mazzocchi A, Porrini M, Fargion S, Agostoni C (2013) Dietary anthocyanins as nutritional therapy for nonalcoholic fatty liver disease. Oxidative Med Cell Longev 2013:1"}, {"Citation": "Tsuda T (2012) Dietary anthocyanin-rich plants: biochemical basis and recent progress in health benefits studies. Mol Nutr Food Res 56(1):159\u2013170", "ArticleIdList": ["22102523"]}, {"Citation": "Koo SI, Noh SK (2007) Green tea as inhibitor of the intestinal absorption of lipids: potential mechanism for its lipid-lowering effect. J Nutr Biochem 18(3):179\u2013183", "ArticleIdList": ["17296491", "1852441"]}, {"Citation": "Ueda M, Nishiumi S, Nagayasu H, Fukuda I, Yoshida K-i, Ashida H (2008) Epigallocatechin gallate promotes GLUT4 translocation in skeletal muscle. Biochem Biophys Res Commun 377(1):286\u2013290", "ArticleIdList": ["18845128"]}, {"Citation": "Wolfram S (2007) Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 26(4):373S\u2013388S", "ArticleIdList": ["17906191"]}, {"Citation": "Stangl V, Lorenz M, Stangl K (2006) The role of tea and tea flavonoids in cardiovascular health. Mol Nutr Food Res 50(2):218\u2013228", "ArticleIdList": ["16404706"]}, {"Citation": "Hakim IA, Harris RB, Brown S, Chow HS, Wiseman S, Agarwal S et al (2003) Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. J Nutr 133(10):3303S\u20133309S", "ArticleIdList": ["14519830"]}, {"Citation": "Kim J-a, Formoso G, Li Y, Potenza MA, Marasciulo FL, Montagnani M et al (2007) Epigallocatechin gallate, a green tea polyphenol, mediates NO-dependent vasodilation using signaling pathways in vascular endothelium requiring reactive oxygen species and Fyn. J Biol Chem 282(18):13736\u201313745", "ArticleIdList": ["17363366"]}, {"Citation": "Khan N, Mukhtar H (2008) Multitargeted therapy of cancer by green tea polyphenols. Cancer Lett 269(2):269\u2013280", "ArticleIdList": ["18501505", "2996277"]}, {"Citation": "Sakata R, Nakamura T, Torimura T, Ueno T, Sata M (2013) Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study. Int J Mol Med 32(5):989\u2013994", "ArticleIdList": ["24065295"]}, {"Citation": "Aboelhadid SM, El-Ashram S, Hassan KM, Arafa WM, Darwish AB (2019) Hepato-protective effect of curcumin and silymarin against Eimeria stiedae in experimentally infected rabbits. Livest Sci 221:33\u201338"}, {"Citation": "Aborehab NM, El Bishbishy MH, Refaiy A, Waly NE (2017) A putative Chondroprotective role for IL-1 beta and MPO in herbal treatment of experimental osteoarthritis. BMC Complement Altern Med 17:495", "ArticleIdList": ["29166937", "5700518"]}, {"Citation": "Imai S (2015) Soybean and processed soy foods ingredients, and their role in cardiometabolic risk prevention. Recent Pat Food Nutr Agric 7(2):75\u201382", "ArticleIdList": ["26118770"]}, {"Citation": "Yang H-Y, Tzeng Y-H, Chai C-Y, Hsieh A-T, Chen J-R, Chang L-S et al (2011) Soy protein retards the progression of non-alcoholic steatohepatitis via improvement of insulin resistance and steatosis. Nutrition 27(9):943\u2013948", "ArticleIdList": ["21333494"]}, {"Citation": "Friedman M, Brandon DL (2001) Nutritional and health benefits of soy proteins. J Agric Food Chem 49(3):1069\u20131086", "ArticleIdList": ["11312815"]}, {"Citation": "Ahn HY, Kim M, Seo CR, Yoo HJ, Lee S-H, Lee JH (2018) The effects of Jerusalem artichoke and fermented soybean powder mixture supplementation on blood glucose and oxidative stress in subjects with prediabetes or newly diagnosed type 2 diabetes. Nutr Diabetes 8(1):42", "ArticleIdList": ["30026514", "6053428"]}, {"Citation": "Goyal A, Sharma V, Upadhyay N, Gill S, Sihag M (2014) Flax and flaxseed oil: an ancient medicine & modern functional food. J Food Sci Technol 51(9):1633\u20131653", "ArticleIdList": ["25190822", "4152533"]}, {"Citation": "Brant LHC, Cardozo LFMF, LGC V, Boaventura GT (2012) Impact of flaxseed intake upon metabolic syndrome indicators in female Wistar rats. Acta Cir Bras 27(8):537\u2013543", "ArticleIdList": ["22850704"]}, {"Citation": "Hutchins AM, Brown BD, Cunnane SC, Domitrovich SG, Adams ER, Bobowiec CE (2013) Daily flaxseed consumption improves glycemic control in obese men and women with pre-diabetes: a randomized study. Nutr Res 33(5):367\u2013375", "ArticleIdList": ["23684438"]}, {"Citation": "Fukumitsu S, Aida K, Shimizu H, Toyoda K (2010) Flaxseed lignan lowers blood cholesterol and decreases liver disease risk factors in moderately hypercholesterolemic men. Nutr Res 30(7):441\u2013446", "ArticleIdList": ["20797475"]}, {"Citation": "Pan A, Yu D, Demark-Wahnefried W, Franco OH, Lin X (2009) Meta-analysis of the effects of flaxseed interventions on blood lipids. Am J Clin Nutr 90(2):288\u2013297", "ArticleIdList": ["19515737", "3361740"]}, {"Citation": "Martin RC, Aiyer HS, Malik D, Li Y (2012) Effect on pro-inflammatory and antioxidant genes and bioavailable distribution of whole turmeric vs curcumin: similar root but different effects. Food Chem Toxicol 50(2):227\u2013231", "ArticleIdList": ["22079310"]}, {"Citation": "Lee H-Y, Kim S-W, Lee G-H, Choi M-K, Chung H-W, Lee Y-C et al (2017) Curcumin and Curcuma longa L. extract ameliorate lipid accumulation through the regulation of the endoplasmic reticulum redox and ER stress. Sci Rep 7(1):6513", "ArticleIdList": ["28747775", "5529367"]}, {"Citation": "Lelli D, Sahebkar A, Johnston TP, Pedone C (2017) Curcumin use in pulmonary diseases: state of the art and future perspectives. Pharmacol Res 115:133\u2013148", "ArticleIdList": ["27888157"]}, {"Citation": "Soleimani V,\u00a0Sahebkar\u00a0A,\u00a0Hosseinzadeh\u00a0H (2018) Turmeric (Curcuma longa) and its major constituent (curcumin) as nontoxic and safe\u00a0substances:\u00a0Review. Phytother Res 32(6):985\u2013995."}, {"Citation": "Sahebkar A, Henrotin Y (2015) Analgesic efficacy and safety of curcuminoids in clinical practice: a systematic review and meta-analysis of randomized controlled trials. Pain Med 17(6):1192\u20131202", "ArticleIdList": ["26814259"]}, {"Citation": "Sahebkar A (2013) Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? Biofactors 39(2):197\u2013208", "ArticleIdList": ["23239418"]}, {"Citation": "Saberi-Karimian, M., Keshvari,\u00a0M., Ghayour-Mobarhan, M., Salehizadeh, L., Rahmani, S., Behnam, B., Jamialahmadi, T., Asgary, S., Sahebkar, A. Effects of curcuminoids on inflammatory status in patients with non-alcoholic fatty liver disease: A randomized controlled trial (2020) Complementary Therapies in Medicine, 49, art. no. 102322. Cited 4 times."}, {"Citation": "Teymouri M, Pirro M,\u00a0Johnston\u00a0TP, Sahebkar A (2017) Curcumin as a multifaceted compound against human papilloma virus infection and cervical cancers: a review of chemistry, cellular, molecular, and preclinical features. Biofactors 43(3):331\u2013346\u00a0"}, {"Citation": "Sadeghian M, Rahmani S,\u00a0Jamialahmadi\u00a0T, Johnston TP, Sahebkar A (2021) The effect of oral curcumin supplementation on health-related quality of life: A systematic review and meta-analysis of randomized controlled trials. J Affect Disord 278:627\u2013636. https://doi.org/10.1016/j.jad.2020.09.091"}, {"Citation": "Iranshahi M, Sahebkar A, Hosseini ST, Takasaki M, Konoshima T, Tokuda H (2010) Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. Phytomedicine 17(3\u20134):269\u2013273", "ArticleIdList": ["19577457"]}, {"Citation": "Mollazadeh H, Cicero AFG, Blesso CN, Pirro M, Majeed M, Sahebkar A (2019) Immune modulation by curcumin: the role of interleukin-10. Crit Rev Food Sci Nutr 59(1):89\u2013101", "ArticleIdList": ["28799796", "28799796"]}, {"Citation": "Momtazi AA, Derosa G, Maffioli P, Banach M, Sahebkar A (2016) Role of microRNAs in the therapeutic effects of curcumin in non-cancer diseases. Mol Diagn Ther 20(4):335\u2013345", "ArticleIdList": ["27241179"]}, {"Citation": "Ghandadi\u00a0M, Sahebkar A (2017)\u00a0Curcumin: An effective inhibitor of interleukin-6. Curr Pharm Des 23(6):921\u2013931.\u00a0"}, {"Citation": "Panahi Y, Ahmadi Y,\u00a0Teymouri\u00a0M, Johnston TP, Sahebkar A (2018) Curcumin as a potential candidate for treating hyperlipidemia: A review of cellular and metabolic\u00a0mechanisms. J Cell\u00a0Physiol 233(1):141\u2013152.\u00a0"}, {"Citation": "Del Gobbo LC, Falk MC, Feldman R, Lewis K, Mozaffarian D (2015) Effects of tree nuts on blood lipids, apolipoproteins, and blood pressure: systematic review, meta-analysis, and dose-response of 61 controlled intervention trials. Am J Clin Nutr 102(6):1347\u20131356", "ArticleIdList": ["26561616", "4658458"]}, {"Citation": "Lin L, Allemekinders H, Dansby A, Campbell L, Durance-Tod S, Berger A et al (2013) Evidence of health benefits of canola oil. Nutr Rev 71(6):370\u2013385", "ArticleIdList": ["23731447", "3746113"]}, {"Citation": "Kruse M, von Loeffelholz C, Hoffmann D, Pohlmann A, Seltmann AC, Osterhoff M et al (2015) Dietary rapeseed/canola-oil supplementation reduces serum lipids and liver enzymes and alters postprandial inflammatory responses in adipose tissue compared to olive-oil supplementation in obese men. Mol Nutr Food Res 59(3):507\u2013519", "ArticleIdList": ["25403327"]}, {"Citation": "Kaczmarczyk MM, Miller MJ, Freund GG (2012) The health benefits of dietary fiber: beyond the usual suspects of type 2 diabetes mellitus, cardiovascular disease and colon cancer. Metabolism 61(8):1058\u20131066", "ArticleIdList": ["22401879", "3399949"]}, {"Citation": "Mudgil D, Barak S (2013) Composition, properties and health benefits of indigestible carbohydrate polymers as dietary fiber: a review. Int J Biol Macromol 61:1\u20136", "ArticleIdList": ["23831534"]}, {"Citation": "Anderson JW, Baird P, Davis RH, Ferreri S, Knudtson M, Koraym A et al (2009) Health benefits of dietary fiber. Nutr Rev 67(4):188\u2013205", "ArticleIdList": ["19335713"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "4", "Day": "16", "Hour": "12", "Minute": "19"}, {"Year": "2021", "Month": "4", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "4", "Day": "21", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33861444", "10.1007/978-3-030-64872-5_13"]}}], "PubmedBookArticle": []}